Lee M. Nadler
Professor
Hematologic OncologyÂ
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Nadler received his MD from Harvard Medical School in 1973. After residency training at Columbia-Presbyterian Medical Center and training at the National Cancer Institute in tumor immunology, he completed a medical oncology fellowship at DFCI, where he joined the staff in 1980. During his tenure at DFCI, he has served as chief and chair of several departments.
Research Interest
Lymphoma, Bone marrow transplant, Immunotherapy
Publications
-
Morgan J, Wen P, Demetri G, Coffman RL, Nadler LM et al (2008) CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans. Clin Cancer Res 17 :5626-5634.
-
Zander T, Yunes JA, Cardoso AA and Nadler LM (2006) Rapid, reliable and inexpensive quality assessment of biotinylated cRNA. Braz J Med Biol Res 5 :589-593.
-
Murray AP, Drury L, Berezovskaya A, Mulligan RC, Nadler LM et al (2007) Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell. Clin Cancer Res 6 :1857-1867.
